Physician
Oncology
Dr. Craig C. Earle, MD
|
|
Give Review
Dr. Craig C. Earle practices Oncology. Craig Earle is a published doctor and has 101 publications published. The lastest was: 'Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.'
Publications
- Comorbid condition care quality in Cancer survivors: role of primary care and specialty providers and care coordination.
- It's who you know: patient-sharing, quality, and costs of Cancer survivorship care.
- Barriers to breast and colorectal Cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States.
- Quality of care for comorbid conditions during the transition to survivorship: differences between Cancer survivors and nonCancer controls.
- Physicians' Beliefs About Breast Cancer Surveillance Testing are Consistent With Test Overuse.
- Surveillance after resection for colorectal Cancer.
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors.
- Referrals for suspected hematologic malignancy: a survey of primary care physicians.
- It Takes a Village.
- Breast Cancer Survivors' Perceptions of Survivorship Care Options.
- Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of Cancer survivors.
- Disparities in Hospice Care among Older Women Dying with Ovarian Cancer.
- Geographic Variation in Physicians' Responses to a Reimbursement Change.
- Cancer Stage Comparison Between Dual Medicare-Medicaid Eligibles Using Medicaid as a Supplemental Health Insurance Program and Low-Income Nonduals.
- Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian Cancer.
- A framework for Cancer survivorship research and translation to policy.
- Hospice Care and Survival among Elderly Patients with Lung Cancer.
- Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: Population-based practices and treatment effectiveness.
- Quality of care for older patients with Cancer in the veterans health administration versus the private sector: a cohort study.
- Preventive care in prostate Cancer patients: following diagnosis and for five-year survivors.
- Advancing performance measurement in oncology.
- Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes.
- Trends in the Aggressiveness of End-of-Life Cancer Care in the Universal Health Care System of Ontario, Canada.
- Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia.
- Lung Cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
- How does initial treatment choice affect short-term and long-term costs for clinically localized prostate Cancer?
- Regional variation in Cancer-directed surgery and mortality among women with epithelial ovarian Cancer in the Medicare population.
- End-of-life care for older Cancer patients in the Veterans Health Administration versus the private sector.
- How medicare's payment cuts for Cancer chemotherapy drugs changed patterns of treatment.
- Associations among Cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care.
- Hospital characteristics, clinical severity, and outcomes for surgical oncology patients.
- Progress for resectable pancreatic [corrected] Cancer?: a population-based assessment of US practices.
- Employment among survivors of lung Cancer and colorectal Cancer.
- Physician factors associated with discussions about end-of-life care.
- The interface between primary and oncology specialty care: treatment through survivorship.
- Racial differences in Cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
- Treatment and outcomes of gastric Cancer among United States-born and foreign-born Asians and Pacific Islanders.
- Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal Cancer.
- Discussions with physicians about hospice among patients with metastatic lung Cancer.
- Comparisons of patient and physician expectations for Cancer survivorship care.
- Comparing care for breast Cancer survivors to non-Cancer controls: a five-year longitudinal study.
- Health care costs in the last week of life: associations with end-of-life conversations.
- Prevention, screening, and surveillance care for breast Cancer survivors compared with controls: changes from 1998 to 2002.
- Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data.
- Behavioral health services for women who have breast Cancer.
- Lifetime and treatment-phase costs associated with colorectal Cancer: evidence from SEER-Medicare data.
- Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon Cancer.
- Provider case volume and outcomes following prostate brachytherapy.
- Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced Cancer.
- Comparison of prospective and retrospective indicators of the quality of end-of-life Cancer care.
- Patterns of care for radical prostatectomy in the United States from 2003 to 2005.
- Racial segregation and disparities in breast Cancer care and mortality.
- Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung Cancer.
- Aggressiveness of Cancer care near the end of life: is it a quality-of-care issue?
- Toward population-based indicators of quality end-of-life care: testing stakeholder agreement.
- Racial segregation and disparities in Cancer stage for seniors.
- Preventive care for colorectal Cancer survivors: a 5-year longitudinal study.
- Trends in follow-up and preventive care for colorectal Cancer survivors.
- Ten-year survival and cost following breast Cancer recurrence: estimates from SEER-medicare data.
- Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder Cancer.
- Use of palliative radiotherapy among patients with metastatic non-small-cell lung Cancer.
- Cancer survivorship research and guidelines: maybe the cart should be beside the horse.
- Referral patterns, treatment choices, and outcomes in locoregional Esophageal cancer: a population-based analysis of elderly patients.
- Mental health service utilization among long-term Cancer survivors.
- Lower use of hospice by Cancer patients who live in minority versus white areas.
- Long term care planning for Cancer survivors: a health services research agenda.
- Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic Cancer.
- Patient and treatment factors associated with complications after prostate brachytherapy.
- Failing to plan is planning to fail: improving the quality of care with survivorship care plans.
- Surgical mortality in patients with Esophageal cancer: development and validation of a simple risk score.
- Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal Cancer.
- Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.
- Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast Cancer.
- Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.
- Do unto others...
- A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.
- Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal Cancer.
- Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal Cancer.
- Does reimbursement influence chemotherapy treatment for Cancer patients?
- Looking back from death: the value of retrospective studies of end-of-life care.
- The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal Cancer.
- Effect of surgeon specialty on processes of care and outcomes for ovarian Cancer patients.
- The effect of race on invasive staging and surgery in non-small-cell lung Cancer.
- A phase II trial of irinotecan in patients with previously untreated advanced Esophageal and gastric adenocarcinoma.
- Racial differences in surgical evaluation, treatment, and outcome of locoregional Esophageal cancer: a population-based analysis of elderly patients.
- Two schedules of second-line irinotecan for metastatic colon carcinoma.
- The economic cost of squamous cell Cancer of the head and neck: findings from linked SEER-Medicare data.
- Under use of necessary care among Cancer survivors.
- Trends in the aggressiveness of Cancer care near the end of life.
- Outcomes research in lung Cancer.
- Patterns of care studies: creating "an environment of watchful concern".
- Treatment of locally advanced pancreatic Cancer in the real world: population-based practices and effectiveness.
- Quality of non-breast Cancer health maintenance among elderly breast Cancer survivors.
- Influenza vaccination in elderly patients with advanced colorectal Cancer.
- Identifying potential indicators of the quality of end-of-life Cancer care from administrative data.
- A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal Cancer.
- Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
- Identifying Cancer relapse using SEER-Medicare data.
- Methodological issues in the use of administrative claims data to study surveillance after Cancer treatment.
- Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.
Schools
University of Ottawa Faculty of Medicine
Ottawa Genl Hospital
University Ottawa
Conditions Treated
- Esophageal Cancer
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Ottawa Faculty of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Elizabeth A. Guancial, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michaela J. Higgins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher Lee Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathy J. Selvaggi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn J. Ruddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leroy M. Parker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jens G. Lohr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. M S. Donnelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pankaj Bhargava, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam J. Bass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina I. Herold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann S. Lacasce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sridhar Ramaswamy, MD
This Doctor is OpenDoctor Recommended.
|